Drugs & Therapy Perspectives

, Volume 2, Issue 9, pp 14–16 | Cite as

Pharmacoeconomic and QOL Analysis in Small Cell Lung Cancer

Drug Economics and Quality of Life
  • 4 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Graham P, Boyages J. PharmacoEconomics 3: 446–453, 1993PubMedCrossRefGoogle Scholar
  2. 2.
    Ruckdescshel JC. Curr Opin Oncol 5: 323–334, 1993CrossRefGoogle Scholar
  3. 3.
    Fayers P. PharmacoEconomics 2: 181–188, 1992PubMedCrossRefGoogle Scholar
  4. 4.
    Medical Research Council Lung Working Party. Br J Cancer 64: 299–306, 1991CrossRefGoogle Scholar
  5. 5.
    Earl HM, et al. Br J Cancer 64: 566–572, 1991PubMedCrossRefGoogle Scholar
  6. 6.
    Medical Research Council Lung Cancer Working Party. Resp Med 83: 51–58, 1989CrossRefGoogle Scholar
  7. 7.
    Anderson H, et al. Br J Cancer 67: 1385–1390, 1993PubMedCrossRefGoogle Scholar
  8. 8.
    Goodwin PJ, et al. J Clin Oncol 6: 1537–1547, 1988PubMedGoogle Scholar
  9. 9.
    Rosenthal MA, et al. Med J Aust 156: 605–610, 1992PubMedGoogle Scholar
  10. 10.
    Faulds D, et al. PharmacoEconomics 1: 231–249, 1992PubMedCrossRefGoogle Scholar
  11. 11.
    Pashko S, Johnson DH. PharmacoEconomics 1:293–297, 1992PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Ltd 1993

Personalised recommendations